The report provides a comprehensive analysis of the potential of Oncology Device and Solution industry in India. The report covers an overview and genesis of the industry, market size in terms of revenue.
Its market segmentations include By Type, By Region, By Clinical Application, By Application, By End Users, By Test Type; growth enablers and drivers; challenges and bottlenecks; trends driving adoption trends; regulatory framework; end-user analysis, industry analysis, competitive landscape including competition scenario and market shares of major players. The report concludes with future market projections of each market segmentation and analyst recommendation’s.
India faces a sizable cancer burden, which continues to grow exponentially and is expected to rise to ~ Mn in 2025.
There are around ~ NABL accredited labs in India, where North and South Region have the maximum number of NABL certified Labs.
Longer-term investments in the public sector are expected to increase for the current private sector exclusive treatments
Its market segmentations include By Type, By Region, By Clinical Application, By Application, By End Users, By Test Type; growth enablers and drivers; challenges and bottlenecks; trends driving adoption trends; regulatory framework; end-user analysis, industry analysis, competitive landscape including competition scenario and market shares of major players. The report concludes with future market projections of each market segmentation and analyst recommendation’s.
Market Overview:
According to publisher estimates India Oncology Devices and Solutions Market (Revenue) has grown at a CAGR of 18.2% from FY’17-22 supported by heightened manufacturing innovation and growing disease awareness. The rising medical devices industry is benefiting the growth of the oncology devices market.India faces a sizable cancer burden, which continues to grow exponentially and is expected to rise to ~ Mn in 2025.
There are around ~ NABL accredited labs in India, where North and South Region have the maximum number of NABL certified Labs.
Key Trends by Market Segment:
- By Clinical Application: In India, amongst all prevalent cancers, the five most common types are breast cancer, lung cancer, oral cancer, stomach cancer and cervical cancer. In India, every four minutes a woman is diagnosed with breast cancer
- By Test Type: Laboratory Cancer Diagnostic Tests like Bloods tests, urinanalysis, tumor markers, etc. account for around ~% of the total oncology tests performed in India. Other tests include tests like genetic tests, biopsies, etc
Competitive Landscape
Future Outlook
India Oncology Devices and Solutions Market (Revenue) is expected to grow at a CAGR of 23.1% from FY’2022-2027 with the oncology devices and solutions market capacity to steadily expand, meeting the underserved and unserved demandLonger-term investments in the public sector are expected to increase for the current private sector exclusive treatments
Additional benefits of purchasing an enterprise license:
- TAM/SAM/SOM Analysis
- Customer Cohort Analysis
- Marketing Initiatives
- White Space Opportunity Analysis
- Interactive Data Visualizations
- Customization: 20 Analyst Hours
- 3 Months Post Sales Analyst Support
- Complimentary Update Next Year
- Custom Webinars
Table of Contents
1. Executive Summary
2. Country Overview
3. India Next-Gen Oncology Devices and Solutions Market Overview
4. Market Segmentation of India Oncology Next-Gen Devices and Solutions Market
5. India Next-Gen Oncology Devices Market
6. India Oncology Solutions (Testing) Market
7. End User Analysis of India Oncology Next-Gen Devices and Solutions Market
8. Industry Analysis of India Oncology Next-Gen Devices and Solutions Market
10. Future Outlook of India Oncology Next-Gen Devices and Solutions Market
11. Market Opportunity and Analyst Recommendations
12. Research Methodology
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Fortis
- Apollo
- Max healthcare
- AIIMS
- Regional cancer centre
- HCG
- TATA
- Dr Lal Path labs
- Elekta
- Accuray
- IBA
- Philips
- GE
